Trials / Terminated
TerminatedNCT00845702
Renal Magnetic Resonance Angiography (MRA) Study Comparing Dotarem and Time Of Flight (TOF)
Evaluation of Dotarem-enhanced Magnetic Resonance Angiography (MRA) Compared to Time-Of-Flight (TOF) MRA in the Diagnosis of Renal Arterial Disease
- Status
- Terminated
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 33 (actual)
- Sponsor
- Guerbet · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The study will evaluate the efficacy and safety of Dotarem enhanced MRA compared to TOF MRA in patients suffering from renal arterial disease.
Detailed description
Each participant will undergo first a TOF MRA followed by a Dotarem-enhanced MRA.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Gadoterate meglumine (Dotarem) | Each subject will receive one injection of Dotarem 0.2 ml/kg |
| OTHER | Time of Flight Magnetic Resonance Angiography | Each subject will undergo a TOF MRA |
Timeline
- Start date
- 2009-04-01
- Primary completion
- 2010-02-01
- Completion
- 2010-02-01
- First posted
- 2009-02-18
- Last updated
- 2016-05-20
- Results posted
- 2012-09-19
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00845702. Inclusion in this directory is not an endorsement.